Biomarx

Pre-Seed
biomarx.co.uk Biotech & Healthcare
Total Funding $940K
Latest Round $940K Pre-Seed
Last Announced Jan 5, 2026
Investors Undisclosed
Decision Makers Profile Active

About Biomarx

Biomarx delivers rapid, low-cost, fully automated liquid biopsy — genomic-grade cancer answers from a blood test in under 2 hours, starting with lung cancer.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Pre-Seed
Global Headquarters Undisclosed
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website biomarx.co.uk
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $940,000 · Pre-Seed

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Biomarx.

Funding History

1 Round
Pre-Seed equity · Jan 5, 2026

Founders & Leadership

1

Sean Macfarlane

Founder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts